RNA
Atrium Therapeutics, Inc.
Nasdaq: RNA · San Diego, CA · Healthcare
$11.76+0.21 (+1.82%)Closed
Market Cap$201.2M
Cash$267.8Mmost recent
Runway26 mo$31.1M Q burn
P/E (TTM)—EPS $-0.97
52-Wk Range$11.55 – $16.54
Avg Volume637.3K3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$11.76-20.3%
Pipeline

Drug candidates sponsored by Atrium Therapeutics · ClinicalTrials.gov

0 drugs · 0 trials
No trials found for this sponsor.
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for RNA. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.